Description

EMPARA FORTE TABLET is an advanced oral antidiabetic medication formulated to support glycemic control in adults with Type 2 Diabetes Mellitus. The formulation commonly contains a combination of Empagliflozin and Metformin, which work synergistically to reduce blood glucose levels by different mechanisms.

Empagliflozin is a selective sodium-glucose co-transporter-2 (SGLT2) inhibitor that reduces blood sugar by preventing glucose reabsorption in the kidneys and promoting its excretion through urine. Metformin, a biguanide, decreases hepatic glucose production and improves insulin sensitivity in the peripheral tissues.

This dual-action tablet not only supports optimal glycemic regulation but also assists in weight management and cardiovascular risk reduction—making it an ideal choice for long-term diabetes care. EMPARA FORTE TABLET is particularly beneficial for patients not adequately controlled with monotherapy.

Manufactured under rigorous quality assurance protocols in WHO-GMP and ISO-certified facilities, EMPARA FORTE TABLET meets international standards for safety, consistency, and therapeutic efficacy. Available for bulk orders, custom packaging, and third-party manufacturing, this product is exclusively distributed worldwide by BLUEPILL EXPRESS.

BLUEPILL EXPRESS is a global exporter of high-quality pharmaceuticals, including antidiabetics, cardiovascular drugs, and lifestyle medications. The company ensures seamless international distribution, regulatory compliance, and product reliability for medical institutions and distributors worldwide.